Pharma’s Almanac’s weekly newsletter, featuring industry news and must-read original content on a range of
topics.
The Road To Series
RoundTable Topics
D
Next-Generation Biologics
What do you see as the next big modality in biologics, and what factors are driving innovation in this space?
N
Normand Blais
J
Joseph Jeong, Ph.D.
G
Gordon Bates
L
Lena Jonsson, Ph.D.
A
Andrea Como
The next big modality in biologics is likely to be cell and gene therapies, including CAR-T therapy, synthetic mRNAs, and gene editing tools like CRISPR. Advancements in gene editing, personalized medicine, and the successful application in cancer and vaccines are driving this growth.
What do you see as the next big modality in biologics, and what factors are driving innovation in this space?
N
Normand Blais
J
Joseph Jeong, Ph.D.
G
Gordon Bates
L
Lena Jonsson, Ph.D.
A
Andrea Como
The next big modality in biologics is likely to be cell and gene therapies, including CAR-T therapy, synthetic mRNAs, and gene editing tools like CRISPR. Advancements in gene editing, personalized medicine, and the successful application in cancer and vaccines are driving this growth.
